Latest news with #Philips
Daily Mirror
2 hours ago
- Business
- Daily Mirror
Philips 'excellent value for money' wireless headphones get price drop
The Philips headphones are on sale in three colourways Headphones can be useful accessories for everyday life. They are ideal for commuting to work, going to the gym, walking the dog, or simply doing the housework. They're not just for listening to music either, they can also be used to take calls and keep up with the latest podcasts. Over at Debenhams, shoppers can currently find a reduction on a pair of Philips wireless headphones, worth £49.99, which are on sale for £34.99. For a limited time, the retailer will include a mystery free gift in consumer electronics worth £10. The Bluetooth-powered headphones are made with a cushioned headband for comfort, soft ear cups that can be angled, and 25 hours of play time when fully charged. Shoppers can choose from black, white, and light brown colorways, however the latter hue has limited stock. A Debenhams buyer said: "Bought these for my teenage daughter at sale price. " Excellent value for money, great product. Would definitely recommend. Daughter loves them." More ratings and reviews can be found on Amazon, where the headphones are also priced at £34.99. One consumer raved about the connectivity between the earphones and other devices. They said: "I've paired with the TV, and they're perfect." "Very good sound but to be listened to at moderate volume to enjoy it", said another shopper. Elsewhere, emerging marketplace Yimbly is selling these JBL wireless noise-cancelling headphones for £79.99, down from £99.99. Yimbly is owned by The Mirror's parent company, Reach PLC. Over at Argos, shoppers can buy these Beats Solo 4 On-Ear Headphones for £199.95. The headphones are foldable, making them easy to store in bags. Going back to the budget Philips pair, another user shared they thought the pair were good value for money. They said: "Nice design, materials with quality in line with the price, it is a good basic product that deserves five stars. "One star less only because at the time of purchase in the description it reported 25 hours of listening but the model selection button reports 50 or 11." Another Amazon customer, however, was not as pleased, writing: "Good sound. However, when it is charged, it cannot be used, and the foam crumbles with use."
Yahoo
2 hours ago
- Health
- Yahoo
Philips to deploy image-guided therapy systems across Indonesia
Health technology company Royal Philips has joined forces with Indonesia's Ministry of Health to implement image-guided therapy systems across the country. This endeavour is part of the Strengthening Indonesia's Healthcare Referral Network (SIHREN) project, which aims to boost treatment for heart disease, stroke, and cancer. Royal Philips CEO Roy Jakobs said: "Delivering better care for more people requires strong partnerships and the best innovations. 'We're honoured to be Indonesia's partner of choice to deliver our innovation directly where it's needed most. More patients in Indonesia will now have access to better care.' The agreements, resulting from an international bidding process, encompass treatment technology, services, and training to fortify the health infrastructure of Indonesia. Funded by the World Bank and other multilateral development banks, the SIHREN project supports the health transformation agenda of the country by enhancing referral healthcare services. The project is set to increase access to minimally invasive treatments in hundreds of hospitals throughout 38 provinces, developing a network of image-guided therapy rooms. The Indonesian Ministry of Health is focused on providing nationwide coverage of the Azurion platform, tailored to the requirements of local hospital infrastructures and patient populations. Philips' chief medical officer Carla Goulart Peron said: 'Minimally invasive care is life-changing for patients, unlocking treatment options that were once unimaginable. With small incisions, such targeted treatments can mean shorter hospital stays, fewer complications and quicker recoveries for patients. 'From opening heart-attack-causing blockages, to treating strokes and targeting cancer tumours, image-guided, minimally invasive therapy will be a game-changer for NCD [non-communicable diseases] care in Indonesia.' Philips has more than 3,900 employees in 12 Indonesian cities and operates a manufacturing facility in Batam for its Personal Health businesses. Recently, the Philips Foundation collaborated with World Child Cancer to promote early detection of childhood cancers in Indonesia. Philips Indonesia president director Astri R Dharmawan said: 'We remain committed to supporting healthcare transformation by delivering innovations that provide better outcomes for patients and improve the experience for healthcare workers. 'Our combined efforts with the Indonesian government will help close healthcare gaps and bring us closer to a Healthy Indonesia.' In October 2024, Philips collaborated with Indonesia's Siloam Hospitals Group to accelerate AI capabilities and advance the country's healthcare sector. "Philips to deploy image-guided therapy systems across Indonesia" was originally created and published by Hospital Management, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Time of India
2 hours ago
- Business
- Time of India
Siemens Healthineers expects up to $580 million tariff impact in 2026
Munich: Siemens Healthineers expects U.S. tariffs to have an impact of up to 500 million euros ($578 million) on 2026 results, its finance chief said on Wednesday, after the European Union and U.S. reached a framework trade agreement on Sunday. The German medical technology company estimates a 400-500 million euro hit in the "most realistic case" for the financial year starting in October, CFO Jochen Schmitz told journalists. He flagged a 200-250 million euro net impact from import duties on the current year. In May, the company had said it expected a 300 million euro hit in the second half of 2025. Its Dutch med-tech peer Philips also slashed its estimated tariff impact for this year on Tuesday. The EU-U.S. deal sets out a 15% import tariff on most EU goods from next month, lower than the 30% U.S. President Donald Trump had threatened to apply earlier in July. With 10% tariffs having already been in place, Schmitz said Siemens Healthineers took a 100 million euro hit in the third quarter, the results of which it reported on Wednesday. Over the medium term, Schmitz said he believed the company would be able to "manage away" all tariff effects. "That will be a combination partly of pricing, but also value-add structure changes under certain circumstances," he said. However, he added that it was too early to make structural decisions as many aspects of the tariff deal were still unclear. Siemens Healthineers also cited the tariff deal when slightly raising its full-year outlook. It expects annual comparable revenue growth of 5.5% to 6%, after previously guiding for 5-6%, and adjusted basic earnings of 2.30-2.45 euros per share, versus 2.20-2.50 euros expected in May. Its revenue was 5.66 billion euros in the third quarter, slightly above analysts' consensus. The company's shares were up 1.6% in Frankfurt as of 0835 GMT.
Reuters
5 hours ago
- Business
- Reuters
Siemens Healthineers expects up to $580 million tariff impact in 2026
July 30 (Reuters) - Siemens Healthineers ( opens new tab expects U.S. tariffs to have an impact of up to 500 million euros ($578 million) on 2026 results, its finance chief said on Wednesday, after the European Union and U.S. reached a framework trade agreement on Sunday. The German medical technology company estimates a 400-500 million euro hit in the "most realistic case" for the financial year starting in October, CFO Jochen Schmitz told journalists. He flagged a 200-250 million euro net impact from import duties on the current year. In May, the company had said it expected a 300 million euro hit in the second half of 2025. Its Dutch med-tech peer Philips ( opens new tab also slashed its estimated tariff impact for this year on Tuesday. The EU-U.S. deal sets out a 15% import tariff on most EU goods from next month, lower than the 30% U.S. President Donald Trump had threatened to apply earlier in July. With 10% tariffs having already been in place, Schmitz said Siemens Healthineers took a 100 million euro hit in the third quarter, the results of which it reported on Wednesday. Over the medium term, Schmitz said he believed the company would be able to "manage away" all tariff effects. "That will be a combination partly of pricing, but also value-add structure changes under certain circumstances," he said. However, he added that it was too early to make structural decisions as many aspects of the tariff deal were still unclear. Siemens Healthineers also cited the tariff deal when slightly raising its full-year outlook. It expects annual comparable revenue growth of 5.5% to 6%, after previously guiding for 5-6%, and adjusted basic earnings of 2.30-2.45 euros per share, versus 2.20-2.50 euros expected in May. Its revenue was 5.66 billion euros in the third quarter, slightly above analysts' consensus. The company's shares were up 1.6% in Frankfurt as of 0835 GMT. ($1 = 0.8656 euros)
Time Business News
8 hours ago
- Business
- Time Business News
8 Powerful Ways MLOps Is Transforming Retail, Healthcare, and Fintech in 2025
Machine learning operations (MLOps) has quickly become the backbone of successful AI adoption across multiple industries, allowing organizations to seamlessly develop, deploy, and scale innovative machine learning solutions. By standardizing workflows, improving collaboration, and automating everything from data management to model monitoring, MLOps boosts both speed and reliability—unlocking industry-specific innovation at an unprecedented pace. Below are eight concrete ways MLOps, including the expertise offered by platforms like MLOpscrew, is powering real-world transformation: Retailers are leveraging MLOps to build and deploy machine learning models for: Product recommendations that adapt to purchase behavior in real time Demand forecasting to optimize inventory and supply chains Automated restocking alerts and dynamic pricing For example, major e-commerce companies have implemented MLOps-enabled workflows to manage hundreds of customer-facing ML models, supporting everything from website search to hyper-personalized promotions. MLOpscrew offers tools that streamline this type of deployment and monitoring, helping retailers drive higher sales and better customer experiences. Healthcare providers are using MLOps to ensure: Faster, more accurate deployment of AI-powered diagnostic and imaging models Continuous monitoring to keep models current as medical data evolves Predictive analytics for patient risk and treatment recommendations Industry leaders like Philips have adopted MLOps solutions to streamline deploying and updating diagnostic models, resulting in faster, more accurate interpretation of medical scans. By partnering with providers such as MLOpscrew, healthcare organizations can automate compliance, ensure data integrity, and accelerate clinical innovation. Fintech companies depend on robust MLOps practices for: Continuous monitoring and retraining of fraud detection models as attack patterns evolve Real-time credit scoring using diverse and dynamic financial data Automation of audit, explainability, and reporting for regulatory compliance As shown by financial leaders who deploy scalable and adaptive fraud prediction models, platforms like MLOpscrew can deliver end-to-end pipelines that keep financial AI models resilient and regulation-ready. Manufacturers adopt MLOps to drive: Predictive maintenance by deploying ML models that analyze sensor data to preempt equipment failure Computer vision for real-time quality control on production lines Efficient asset management and process optimization Organizations implementing MLOps practices have seen dramatic reductions in machine downtime and significant cost savings by automating model updates and maintenance alerts. MLOpscrew provides the necessary tooling to scale these solutions securely in industrial settings. E-commerce leaders use MLOps for: Orchestrating personalized search, recommendations, and dynamic pricing across multiple platforms Managing rapid updates to production models as user behavior shifts Streamlining the deployment of AI-powered marketing and fraud prevention tools for instance, scaled to hundreds of AI models live in production using MLOps best practices. MLOpscrew can support the integration and monitoring of these complex pipelines, keeping e-commerce experiences engaging and secure. Agritech companies benefit from MLOps by: Managing massive volumes of data from drone imagery and IoT sensors Deploying and updating models that forecast crop yields or detect issues from the field Efficiently training models on evolving environmental and climate data With MLOps practices, companies have scaled their data processing capabilities by 100x, improving both the accuracy and efficiency of their analytics platforms. MLOpscrew enables this growth through sophisticated pipeline automation and data management tools. Telecommunications providers depend on MLOps for: Predicting customer churn and enabling proactive retention strategies Optimizing network performance and reliability via automated anomaly detection Continuous retraining to adapt models to changing user behavior Using MLOps platforms, telecom leaders ensure their models remain accurate, up-to-date, and scalable across growing data streams, driving better customer satisfaction and business agility. MLOpscrew can help telecoms maintain these robust, always-on systems. Pharma companies leverage MLOps for: Accelerating drug candidate identification through high-throughput data analytics Automating model evaluation as new molecular and trial data arrives Enabling reproducible and scalable research workflows By integrating MLOps into R&D pipelines, pharma giants have drastically reduced time-to-discovery for promising drug candidates and improved the reliability of clinical predictions. MLOpscrew provides secure and compliant frameworks to support these demanding data science requirements. MLOps is now central to real-world AI innovation, unlocking new opportunities in every sector—from retail and healthcare to manufacturing, fintech, and beyond. If your organization is ready to accelerate its own AI journey, consider partnering with MLOpscrew—a leading platform dedicated to simplifying, securing, and scaling machine learning operations across industries. TIME BUSINESS NEWS
